A comparison of six major platelet functional tests to assess the impact of carbon nanomaterials on platelet function: A practical guide

Nanotoxicology

Volumn 8, Issue 2, 2014, Pages 220-232

  Laloy, Julie ^a,b   Mullier, François ^a,b,c   Alpan, Lutfiye ^a,b   Mejia, Jorge ^a,b   Lucas, Stéphane ^a,b   Chatelain, Bernard ^b,c   Toussaint, Olivier ^a,b   Masereel, Bernard ^a,b   Rolin, Stéphanie ^a,b   Dogné, Jean Michel ^a,b  

^a UNIVERSITY OF NAMUR   (Belgium)

^b University of Namur   (Belgium)

^c UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Blood; Haemocompatibility; Impact R; Nanoparticles; Platelets

Indexed keywords

CARBON BLACK; CARBON NANOTUBE; FULLERENE DERIVATIVE; MULTI WALLED NANOTUBE; SINGLE WALLED NANOTUBE; UNCLASSIFIED DRUG;

ARTICLE; BLOOD CLOTTING PARAMETERS; CONE AND PLATE(LET) ANALYSER; FIELD EMISSION SCANNING ELECTRON MICROSCOPY; HEMOSTASIS; IMPEDANCE; IN VITRO STUDY; INTERMETHOD COMPARISON; LIGHT TRANSMISSION AGGREGOMETRY; PHYSICAL CHEMISTRY; PLATELET FUNCTION ANALYSER 100; PRIORITY JOURNAL; REPRODUCIBILITY; SCREENING TEST; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOCYTE FUNCTION ANALYZER; THROMBOCYTE RICH PLASMA; THROMBOCYTE STRUCTURE; TRANSMISSION AND FIELD EMISSION GUN SCANNING ELECTRON MICROSCOPY; VALIDATION STUDY; WHOLE BLOOD IMPEDANCE AGGREGOMETRY;

BLOOD PLATELETS; CARBON; HUMANS; NANOSTRUCTURES; PLATELET FUNCTION TESTS; TOXICITY TESTS;

EID: 84890387826     PISSN: 17435390     EISSN: 17435404     Source Type: Journal    
DOI: 10.3109/17435390.2013.788750     Document Type: Article

References (52)

1. Bakry R, Vallant RM, Najam-ul-Haq M, Rainer M, Szabo Z, Huck CW, et al. 2007. Medicinal applications of fullerenes. Int J Nanomedicine 2:639-649
2. Barlow PG, Donaldson K, MacCallum J, Clouter A, Stone V. 2005. Serum exposed to nanoparticle carbon black displays increased potential to induce macrophage migration. Toxicol Lett 155:397-401
3. Bihari P, Holzer M, Praetner M, Fent J, Lerchenberger M, Reichel CA, et al. 2010. Single-walled carbon nanotubes activate platelets and accelerate thrombus formation in the microcirculation. Toxicology 269:148-154
4. Burke AR, Singh RN, Carroll DL, Owen JD, Kock ND, D'Agostino R Jr, et al. 2011. Determinants of the thrombogenic potential ofmultiwalled carbon nanotubes. Biomaterials 32:5970-5978
5. Dobrovolskaia MA, Aggarwal P, Hall JB, McNeil SE. 2008a. Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. Mol Pharm 5:487-495
6. Dobrovolskaia MA, Clogston JD, Neun BW, Hall JB, Patri AK, McNeil SE. 2008b. Method for analysis of nanoparticle hemolytic properties in vitro. Nano Lett 8:2180-2187
7. Donaldson K, Brown D, Clouter A, Duffin R, MacNee W, Renwick L, et al. 2002. The pulmonary toxicology of ultrafine particles. J Aerosol Med 15:213-220
8. Favaloro EJ. 2009. Internal quality control and external quality assurance of platelet function tests. Semin Thromb Hemost 35:139-149
9. Favaloro EJ, Lippi G, Franchini M. 2010. Contemporary platelet function testing. Clin Chem Lab Med 48:579-598
10. Ferraz N, Carlsson J, Hong J, Ott MK. 2008. Influence of nanoporesize on platelet adhesion and activation. J Mater Sci Mater Med 19:3115-3121
11. Geys J, Nemmar A, Verbeken E, Smolders E, Ratoi M, Hoylaerts MF, et al. 2008. Acute toxicity and prothrombotic effects of quantum dots: Impact of surface charge. Environ Health Perspect 116:1607-1613
12. Gouya G, Jilma B, Niel M, Eichelberger B, Wolzt M, Panzer S. 2009. Cross validation of aspirin effect in healthy individuals by Impact-R and PFA-100: A double blind randomized placebo controlled trial. Platelets 20:171-176
13. Harrison P, Mumford A. 2009. Screening tests of platelet function: Update on their appropriate uses for diagnostic testing. Semin Thromb Hemost 35:150-157
14. Hulstein JJ, Lenting PJ, de Laat B, Derksen RH, Fijnheer R, de Groot PG. 2007. beta2-Glycoprotein I inhibits von Willebrand factor dependent platelet adhesion and aggregation. Blood 110:1483-1491
15. Jiang J, Oberdörster G, Biswas P. 2009. Characterization of size, surface charge, and agglomeration state of nanoparticle dispersions for toxicological studies. J Nanopart Res 11:77-89
16. Jun EA, Lim KM, Kim K, Bae ON, Noh JY, Chung KH, et al. 2011. Silver nanoparticles enhance thrombus formation through increased platelet aggregation and procoagulant activity. Nanotoxicology 5 (2):157-167
17. Karagkiozaki VC, Logothetidis SD, Kassavetis SN, Giannoglou GD. 2010. Nanomedicine for the reduction of the thrombogenicity of stent coatings. Int J Nanomedicine 5:239-248
18. Kundu SK, Heilmann EJ, Sio R, Garcia C, Davidson RM, Ostgaard RA. 1995. Description of an in vitro platelet function analyzer-PFA-100. Semin Thromb Hemost 21(Suppl 2):106-112
19. Lacerda SH, Semberova J, Holada K, Simakova O, Hudson SD, Simak J. 2010. Carbon nanotubes activate store-operated calcium entry in human blood platelets. ACS Nano 5:5808-5813
20. Mayer A, Vadon M, Rinner B, Novak A, Wintersteiger R, Frohlich E. 2009. The role of nanoparticle size in hemocompatibility. Toxicology 258:139-147
21. Mejia J, Tichelaar F, Saout C, Toussaint O, Masereel B, Mekhalif Z, et al. 2011. Effects of the dispersion methods in Pluronic F108 on the size and the surface composition of MWCNTs and their implications in toxicology assessment. J Nanopart Res 13:655-667
22. Mengistu AM, Mayer J, Boldt J, Rohm KD. 2009. Whole-blood aggregometry: Are there any limits with regard to platelet counts? Acta Anaesthesiol Scand 53:72-76
23. Michelson AD, Linden MD, Furman MI, Li Y, Barnard MR, Fox ML, et al. 2007. Evidence that pre-existent variability in platelet response to ADP accounts for 'clopidogrel resistance'. J Thromb Haemost 5:75-81
24. Miller G, Senjen R. 2008. Out of the laboratory and on to our plates. Nanotechnology in food & agriculture. Friends Earth 1-63
25. Moghimi SM, Hunter AC, Murray JC. 2005. Nanomedicine: Current status and future prospects. FASEB J 19:311-330
26. Morel-Kopp MC, Aboud M, Tan CW, Kulathilake C, Ward C. 2010. Whole blood impedance aggregometry detects heparin-induced thrombocytopenia antibodies. Thromb Res 125:e234-e239
27. Nel AE, Madler L, Velegol D, Xia T, Hoek EM, Somasundaran P, et al. 2009. Understanding biophysicochemical interactions at the nano-bio interface. Nat Mater 8:543-557
28. Nemmar A, Hoet PH, Vandervoort P, Dinsdale D, Nemery B, Hoylaerts MF. 2007. Enhanced peripheral thrombogenicity after lung inflammation is mediated by platelet-leukocyte activation: Role of P-selectin. J Thromb Haemost 5:1217-1226
29. Nie S, Xing Y, Kim GJ, Simons JW. 2007. Nanotechnology applications in cancer. Annu Rev Biomed Eng 9:257-288
30. Nyman D. 1977. Collagen-induced platelet aggregation: Evidence of several mechanisms for the induction of platelet release by collagen. Thromb Res 10:743-751
31. Oberdorster G, Maynard A, Donaldson K, Castranova V, Fitzpatrick J, Ausman K, et al. 2005. Principles for characterizing the potential human health effects from exposure to nanomaterials: Elements of a screening strategy. Part Fibre Toxicol 2. 8
32. Panzer S, Jilma P. 2011. Methods for testing platelet function for transfusion medicine. Vox Sang 101:1-9
33. Panzer S, Rieger M, Vormittag R, Eichelberger B, Dunkler D, Pabinger I. 2007. Platelet function to estimate the bleeding risk in autoimmune thrombocytopenia. Eur J Clin Invest 37:814-819
34. Patel DN, Bailey SR. 2007. Nanotechnology in cardiovascular medicine. Catheter Cardiovasc Interv 69:643-654
35. Piret JP, Detriche S, Vigneron R, Vankoningsloo S, Rolin S, Mejia Mendoza JH, et al. 2010. Dispersion of multi-walled carbon nanotubes in biocompatible dispersants. J Nanopart Res 12:75-82
36. Powers KW, Brown SC, Krishna VB, Wasdo SC, Moudgil BM, Roberts SM. 2006. Research strategies for safety evaluation of nanomaterials. Part VI. Characterization of nanoscale particles for toxicological evaluation. Toxicol Sci 90:296-303
37. Radomski A, Jurasz P, Alonso-Escolano D, Drews M, Morandi M, Malinski T, et al. 2005. Nanoparticle-induced platelet aggregation and vascular thrombosis. Br J Pharmacol 146:882-893
38. Ryan JJ, Bateman HR, Stover A, Gomez G, Norton SK, Zhao W, et al. 2007. Fullerene nanomaterials inhibit the allergic response. J Immunol 179:665-672
39. Santos-Martinez MJ, Inkielewicz-Stepniak I, Medina C, Rahme K, D'Arcy DM, Fox D, et al. 2012. The use of quartz crystal microbalance with sissipation (QCM-D) for studying nanoparticle-induced platelet aggregation. Int J Nanomedicine 7:243-255
40. Semberova J, De Paoli Lacerda SH, Simakova O, Holada K, Gelderman MP, Simak J. 2009. Carbon nanotubes activate blood platelets by inducing extracellular Ca2+ influx sensitive to calcium entry inhibitors. Nano Lett 9:3312-3317
41. Semberova J, Holada K, Simakova O, Gelderman-Fuhrmann MP, Simak J. 2008. Carbon nanotubes activate platelets by facilitating extracellular Ca(2+) influx. Blood 112:365-366
42. Shrivastava S, Bera T, Singh SK, Singh G, Ramachandrarao P, Dash D. 2009. Characterization of antiplatelet properties of silver nanoparticles. ACS Nano 3:1357-1364
43. Simak J. 2009. Nanotoxicity in blood: Effects of engineered nanomaterails on platelets. In: Sahu SC, Cascaciano DA, editors. Nanotoxicity: From in vivo and in vitro models to health risks. John Wiley & Sons. Chichester: Pp. 191-225
44. Singh SK, Singh MK, Nayak MK, Kumari S, Shrivastava S, Gracio JJA, et al. 2011. Thrombus inducing property of atomically thin graphene oxide sheets. ACS Nano 5(6):4987-4996
45. Singh SK, Singh MK, Kulkarni PP, Sonkar VK, Gracio JJA, Dash D. 2012. Amine-modified graphene: Thrombo-protective safer alternative to graphene oxide for biomedical applications. ACS Nano 6(3):2731-2740
46. Sitharaman B, Shi X, Walboomers XF, Liao H, Cuijpers V, Wilson LJ, et al. 2008. In vivo biocompatibility of ultra-short single-walled carbon nanotube/biodegradable polymer nanocomposites for bone tissue engineering. Bone 43:362-370
47. Smyth SS, McEver RP, Weyrich AS, Morrell CN, Hoffman MR, Arepally GM, et al. 2009. Platelet functions beyond hemostasis. J Thromb Haemost 7:1759-1766
48. Stevens KN, Knetsch ML, Sen A, Sambhy V, Koole LH. 2009. Disruption and activation of blood platelets in contact with an antimicrobial composite coating consisting of a pyridinium polymer and AgBr nanoparticles. ACS Appl Mater Interfaces 1:2049-2054
49. Tirosh-Wagner T, Strauss T, Rubinshtein M, Tamarin I, Mishaly D, Paret G, et al. 2011. Point of care testing in children undergoing cardiopulmonary bypass. Pediatr Blood Cancer 56:794-798
50. van Werkum JW, Bouman HJ, Breet NJ, ten Berg JM, Hackeng CM. 2010. The Cone-And-Plate(let) analyzer is not suitable to monitor clopidogrel therapy: A comparison with the flowcytometric VASP assay and optical aggregometry. Thromb Res 126:44-49
51. Vankoningsloo S, Piret JP, Saout C, Noel F, Mejia J, Zouboulis CC, et al. 2010. Cytotoxicity of multi-walled carbon nanotubes in three skin cellular models: Effects of sonication, dispersive agents and corneous layer of reconstructed epidermis. Nanotoxicology 4:84-97
52. Zuo L, Wei W, Morris M, Wei J, Gorbounov M, Wei C. 2007. New technology and clinical applications of nanomedicine. Med Clin North Am 91:845-862